Research ArticleAccepted Article
Treating Psoriatic Arthritis to Target: Defining Psoriatic Arthritis Disease Activity Score (PASDAS) That Reflects State Of Minimal Disease Activity (MDA)
Anthony V. Perruccio, Matthew Got, Suzanne Li, Yang Ye, Dafna D. Gladman and Vinod Chandran
The Journal of Rheumatology June 2019, jrheum.181472; DOI: https://doi.org/10.3899/jrheum.181472
Anthony V. Perruccio
From the Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Health Care & Outcomes Research and Arthritis Program, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada; Department of Surgery, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. Address correspondence to Dr. Vinod Chandran Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Disease Toronto Western Research Institute, University Health Network 399 Bathurst Street 1E-410B, Toronto, Ontario, Canada, M5T 2S8. Email: vinod.chandran@uhnresearch.ca
Matthew Got
From the Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Health Care & Outcomes Research and Arthritis Program, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada; Department of Surgery, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. Address correspondence to Dr. Vinod Chandran Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Disease Toronto Western Research Institute, University Health Network 399 Bathurst Street 1E-410B, Toronto, Ontario, Canada, M5T 2S8. Email: vinod.chandran@uhnresearch.ca
Suzanne Li
From the Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Health Care & Outcomes Research and Arthritis Program, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada; Department of Surgery, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. Address correspondence to Dr. Vinod Chandran Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Disease Toronto Western Research Institute, University Health Network 399 Bathurst Street 1E-410B, Toronto, Ontario, Canada, M5T 2S8. Email: vinod.chandran@uhnresearch.ca
Yang Ye
From the Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Health Care & Outcomes Research and Arthritis Program, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada; Department of Surgery, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. Address correspondence to Dr. Vinod Chandran Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Disease Toronto Western Research Institute, University Health Network 399 Bathurst Street 1E-410B, Toronto, Ontario, Canada, M5T 2S8. Email: vinod.chandran@uhnresearch.ca
Dafna D. Gladman
From the Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Health Care & Outcomes Research and Arthritis Program, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada; Department of Surgery, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. Address correspondence to Dr. Vinod Chandran Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Disease Toronto Western Research Institute, University Health Network 399 Bathurst Street 1E-410B, Toronto, Ontario, Canada, M5T 2S8. Email: vinod.chandran@uhnresearch.ca
Vinod Chandran
From the Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Health Care & Outcomes Research and Arthritis Program, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada; Department of Surgery, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. Address correspondence to Dr. Vinod Chandran Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Disease Toronto Western Research Institute, University Health Network 399 Bathurst Street 1E-410B, Toronto, Ontario, Canada, M5T 2S8. Email: vinod.chandran@uhnresearch.ca
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Accepted manuscript
Treating Psoriatic Arthritis to Target: Defining Psoriatic Arthritis Disease Activity Score (PASDAS) That Reflects State Of Minimal Disease Activity (MDA)
Anthony V. Perruccio, Matthew Got, Suzanne Li, Yang Ye, Dafna D. Gladman, Vinod Chandran
The Journal of Rheumatology Jun 2019, jrheum.181472; DOI: 10.3899/jrheum.181472
Accepted manuscript
Treating Psoriatic Arthritis to Target: Defining Psoriatic Arthritis Disease Activity Score (PASDAS) That Reflects State Of Minimal Disease Activity (MDA)
Anthony V. Perruccio, Matthew Got, Suzanne Li, Yang Ye, Dafna D. Gladman, Vinod Chandran
The Journal of Rheumatology Jun 2019, jrheum.181472; DOI: 10.3899/jrheum.181472